Literature DB >> 11272162

Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria.

C J Greenbaum1, D Cuthbertson, J P Krischer.   

Abstract

The clinical presentation of type 1 diabetes usually involves symptoms such as polyuria and polydipsia. However, investigators in the Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) have detected a group of subjects with type 1 diabetes who have a different phenotype. These subjects are asymptomatic, have normal (<6.1 mmol/l) (group A) or impaired (6.1- <7.0 mmol/l) (group B) fasting glucose, but have 2-h glucose values >11.1 mmol/l on their oral glucose tolerance tests (OGTT). Of the 585 OGTTs performed on islet cell antibody (ICA)-positive relatives with insulin autoantibodies (IAA) or low first-phase insulin response (FPIR), normal glucose tolerance (NGT) was found in 427 subjects; impaired glucose tolerance (IGT) was found in 87 subjects, and diabetes was found by 2-h OGTT criteria alone in 61 subjects. Despite marked differences in 2-h glucose values (NGT 5.8 +/- 1.1 mmol/l, IGT 8.9 +/- 0.9 mmol/l, and group A 13.5 +/- 2.5 mmol/l), there were no significant differences in fasting glucose values among NGT (4.8 +/- 0.5 mmol/l), IGT (5.03 +/- 0.5 mmol/l), and group A (4.99 +/- 0.7 mmol/l) categories. Mean FPIR was higher in subjects with NGT compared with subjects with IGT and subjects diagnosed by 2-h OGTT criteria alone. However, the correlation between FPIR and 2-h glucose value was low (r2 = 0.114). Multivariate analysis demonstrated that additional independent variables provide smaller contributions to the 2-h glucose value. In conclusion, there are asymptomatic type 1 diabetic subjects whose diabetes was diagnosed by the 2-h criteria on OGTT alone. Despite the importance of beta-cell dysfunction in the pathogenesis of type I diabetes, factors other than impaired FPIR must also contribute to postprandial glucose tolerance in these subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272162     DOI: 10.2337/diabetes.50.2.470

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  20 in total

1.  Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting.

Authors:  P A Velasquez-Mieyer; P A Cowan; C P Neira; F Tylavsky
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

Authors:  Jennifer M Barker; Kim McFann; Leonard C Harrison; Spiros Fourlanos; Jeffrey Krischer; David Cuthbertson; H Peter Chase; George S Eisenbarth
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

Review 3.  Prediabetes in children: natural history, diagnosis, and preventive strategies.

Authors:  Petri Kulmala
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis.

Authors:  Olli Helminen; Susanna Aspholm; Tytti Pokka; Jorma Ilonen; Olli Simell; Riitta Veijola; Mikael Knip
Journal:  Diabetologia       Date:  2015-05-19       Impact factor: 10.122

5.  Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients.

Authors:  E Vandemeulebroucke; B Keymeulen; K Decochez; I Weets; C De Block; F Féry; U Van de Velde; I Vermeulen; P De Pauw; C Mathieu; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

6.  Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance.

Authors:  Olfat G Shaker; Nermin Abdel Hamid Sadik
Journal:  Mol Cell Biochem       Date:  2012-11-08       Impact factor: 3.396

7.  Characterising the age-dependent effects of risk factors on type 1 diabetes progression.

Authors:  Michelle So; Colin O'Rourke; Alyssa Ylescupidez; Henry T Bahnson; Andrea K Steck; John M Wentworth; Brittany S Bruggeman; Sandra Lord; Carla J Greenbaum; Cate Speake
Journal:  Diabetologia       Date:  2022-01-18       Impact factor: 10.122

8.  Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.

Authors:  Taylor M Triolo; H Peter Chase; Jennifer M Barker
Journal:  Diabetes Care       Date:  2009-05       Impact factor: 17.152

9.  Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus.

Authors:  Megu Yamaguchi Baden; Akihisa Imagawa; Hiromi Iwahashi; Iichiro Shimomura; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2015-12-29

10.  One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes.

Authors:  Kimber M Simmons; Jay M Sosenko; Megan Warnock; Susan Geyer; Heba M Ismail; Helena Elding Larsson; Andrea K Steck
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.